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Abstract 
 
Background: The third most common healthcare-associated infection is surgical site infection 
(SSI), accounting for 14%–16% of infections. These SSIs are associated with high morbidity, 
numerous deaths, and greater cost. Methods: A prospective study was conducted to assess the 
incidence of SSI in a single university hospital in Croatia. We used the Hospital in Europe 
Link for Infection Control through Surveillance (HELICS) protocol for surveillance. The SSIs 
were classified using the standard definition of the National Nosocomial Infections 
Surveillance (NNIS) system. Results: The overall incidence of SSI was 1.44%. The incidence 
of infection in the open cholecystectomy group was 6.06%, whereas in the laparoscopic 
group, it was only 0.60%. The incidence density of in-hospital SSIs per 1,000 post-operative 
days was 5.76. Patients who underwent a laparoscopic cholecystectomy were significantly 
younger (53.65 – 14.65 vs. 64.42 – 14.17 years; p < 0.001), spent roughly one-third as many 
days in the hospital (2.40 – 1.72 vs. 8.13 – 4.78; p < 0.001), and had significantly shorter 
operations by nearly 26 min (60.34 – 28.34 vs. 85.80 – 37.17 min; p < 0.001). Procedures that 
started as laparoscopic cholecystectomies and were converted to open procedures (n = 28) 
were reviewed separately. The incidence of SSI in this group was 17.9%. The majority of 
converted procedures (71.4%) were elective, and the operating time was significantly longer 
than in other two groups (109.64 – 85.36 min). Conclusion: The HELICS protocol has a good 
concept for the monitoring of SSI, but in the case of cholecystectomy, additional factors such 
as antibiotic appropriateness, gallbladder entry, empyema of the gallbladder, and obstructive 
jaundice must be considered. 
 
Introduction 
 
Patients acquire healthcare-associated infections during treatment for other conditions. The 
third most commonly reported healthcare-associated infection is surgical site infection (SSI), 
accounting for 14%–16% of infections reported. These SSIs are associated with high 
morbidity, mortality rate, and cost [1–5]. In Croatia, several epidemiologic projects are 
monitoring infections of surgical sites, but each has its own standards. We decided to use the 
Hospital in Europe Link for Infection Control through Surveillance (HELICS) protocol, as the 
majority of European Union countries employ it [6]. The HELICS protocol monitors surgical 
procedures in six categories: Coronary artery bypass graft, cholecystectomy, colon surgery, 
caesarean section, hip prosthesis placement, and laminectomy. We decided to monitor SSI 
after cholecystectomies, as that is one of the most common surgical procedures in our facility 
[6]. Incidence of SSI after cholecystectomy ranges from 1.3% to 4.4%. The several risk 
factors are male gender, older age, emergency procedure, prolonged surgery ( > 2 h), high 
American Society of Anesthesiologists (ASA) score, positive bile culture, open 
cholecystectomy, and multiple procedures [1–5, 7–10].  
 
Patients and Methods 
 
In this prospective study, data were collected on patients who underwent open or laparoscopic 
cholecystectomy from December 2009 to June 2011 in University Hospital Centre, Zagreb, 
Croatia. Patients who had another procedure along with a cholecystectomy (i.e., hernioplasty) 
were not included. We classified SSI using the definition of the National Nosocomial 
Infections Surveillance (NNIS) system [11]. A standard form was completed for each patient 
consisting of general data (hospital code, operative procedure, age at date of operation, 
gender, date of admission, date of operation, date of discharge or of last follow-up in hospital, 
discharge status, and NNIS operative code); stratification and preoperative data (endoscopic 
procedure, wound contamination class, duration of operation [min], urgent/elective operation, 
ASA physical status classification, peri-operative prophylactic antibiotic); and infection data 
(type of SSI, date of infection, microorganism isolated, antibiotic resistance pattern of 
microorganism) [6]. Procedures that started as laparoscopic cholecystectomies and were 
converted in an open procedure were classified in a third group. All patients were followed up 
for 30 days after hospital discharge. Normality of data distribution was assessed using the 
Smirnov-Kolmogorov test, and according to the results, appropriate parametric or non-
parametric tests were applied. Differences between operative procedures were analyzed with 
the w2 test with Yates correction (categorical values) or independent t-test (quantitative 
values). Binary logistic regression was performed to assess the impact of a number of factors 
on the likelihood that patients would develop an infection. All p values < 0.05 were 
considered significant. Data analysis software STATISTICA version 9.1 (StatSoft, Inc., 
Tulsa, OK) was used. 
 
 
Results 
 
The incidence of SSI was 1.44% (12/832). The incidence density in-hospital SSI per 1,000 
postoperative days was5.76. Table 1 gives the descriptive statistics and differences between 
the operations. Significant differences were noted in all investigated variables and suggested 
that laparoscopic cholecystectomy was performed more often on female patients (69.70% vs. 
53.79%; p < 0.001). In comparison, most cases of laparoscopic cholecystectomy were 
elective, and the patients had lower ASA scores. Most antibiotic prophylaxis was 
administered when open cholecystectomy was preformed (75% vs. 12.7%). The percentage of 
infection in patients who underwent open cholecystectomy was 10 times hat of patients who 
had a laparoscopic cholecystectomy (6.06% vs. 0.6%; p < 0.001). Infections in patients 
having emergency open procedures occurred in 9.09% of cases, and in the emergency 
laparoscopic group in 3.57%. The open surgery group had a 2.27% rate of infections and the 
laparoscopic group 0.16%. Table 2 shows the descriptive statistics and differences in 
quantitative variables between operational procedures. Patients who had a laparoscopic 
cholecystectomy were significantly younger (53.65 – 14.65 vs. 64.42 – 14.17 years; p < 
0.001), spent one-third as long in the hospital (2.40 – 1.72 vs. 8.13 – 4.78 days; p < 0.001), 
and had significantly shorter operations by 26 min (60.34 – 28.34 vs. 85.80 – 37.17 min; p < 
0.001). Binary logistic regression was performed to assess the impact of a number of factors 
on the likelihood that patients would develop an infection. The model contained eight 
independent variables Gender: age, hospital length of stay, operation duration, emergency or 
not, ASA score, and antibiotic prophylaxis. The full model containing all predictors was 
statistically significant (w2 8; N= 832) = 50.59; p < 0.001, indicating that the model could 
distinguish between patients who had and did not have infection. The model as a whole 
explained 30.5% (Nagelkerke R2) of the variance in symptomatology and correctly classified 
98.4% of cases. As Table 3  shows, four of the independent variables made a statistically 
unique contribution to the model. This indicated that male patients had 5.11 times the risk of 
developing SSI, patients who had an open cholecystectomy had 4.67 times the risk, and 
patients who had longer operations had 1.01 times the risk when controlling for all other 
factors in the model. Procedures that started as laparoscopic cholecystectomies and were 
converted in an open procedure were performed in 28 patients. The incidence of SSI in this 
group was 17.9%. The majority were procedures were elective at 71.4%, and, as expected, the 
operating time was significantly longer than in other two groups (109.64 – 85.36 min). The 
pre-operative hospital stay had no impact on the risk of infection. Overall, the pre-operative 
stay was 0.87 days. In the laparoscopic group, it was 1.06 days; in the open group, it was 0.57 
days, and in the group having laparoscopic cholecystectomy converted to an open procedure, 
it was 0.82 days. Among patients having infections, the pre-operative stay in the laparoscopic 
group was zero days, in the open group 0.286 days, and in the third group 0.6 days. According 
to the distribution of risk index, the majority of patients were classified in NNIS 0 group 
(77.6%), the remainder being in NNIS 1 group (20.8%) or NNIS 2–3 (1.5%). Using the 
standard definition of the NNIS system (laparoscopic and open cholecystectomy), 66.67% of 
the SSIs (8/12) were superficial incisional, 8.33% (1/12) deep incisional, and 25% (3/12) 
organ/space. In the third group, 80% of the infections were superficial incisional (4/5) and 
20% deep incisional. In ten cases, wound swabs were taken, and bacteria were isolated in five 
cases. In all patients, Escherichia coli was the organism recovered. In three patients, E. coli 
was combined with coagulase-negative staphylococci, Enterococcus faecium, or extended-
spectrum beta-lactamase (ESBL)-positive Klebsiella pneumoniae. The other swabs were 
sterile. In two cases, E. coli was resistant to amoxicillin, and the ESBL K. Pneumoniae was 
sensitive to aminoglycosides and carbapenems. 
 
Discussion 
 
We surveyed the incidence of SSI after cholecystectomy using the HELICS protocol, as this 
operative procedure is one of the most common being performed in our facility [6]. Prior to 
conducting this surveillance, we did not have genuine insight into the incidence of SSI after 
cholecystectomy in our hospital because of the lack of systematic monitoring. This research 
has set clear criteria to define risk factors and mode of prevention. The overall incidence of 
SSI was 1.44%. The infection rate in open cholecystectomy was 6.06%, whereas in the 
laparoscopic group, it was only 0.6%. As in our study, Richards et al. concluded that SSI rates 
after cholecystectomy should be stratified by technique [8]. As expected, most laparoscopic 
cholecystectomies were elective, as those patients were younger, had lower ASA scores, and 
shorter mean duration of operation and thus a lower risk of developing SSI. Male patients 
were five times more likely to develop postoperative infections. We attribute this to their 
older age and higher ASA scores, although the differences were not statistically significant. 
Patients who had emergency procedures were more often treated with the open operation. In 
our emergency department, general surgeons rotate daily, and there is a variation in the extent 
of laparoscopic experience among them. Emergency patients often have complicated intra-
operative findings, so the use of the open approach is not surprising. These patients had higher 
ASA scores, and thus a higher risk of SSI. In our study, emergency open procedures had the 
highest infection rate, at 9.09%,whereas elective open procedures had a 2.27% rate of SSI. 
There were nine patients between four and 18 years of age. All procedures in this group were 
elective and were performed laparoscopically. None of them developed infection. As Esposito 
et al. reported, pediatric patients are more demanding than adults because of possible 
congenital biliary abnormalities; nevertheless, the laparoscopic approach is as effective as 
open surgery [12]. Prophylactic antibiotics were administrated to all patients having 
emergency procedures, including those who had operations (open or laparoscopic) lasting 
longer than 120 min, and when the intra-operative finding was empyema of the gallbladder. In 
the 28 patients having laparoscopic cholecystectomies converted to open surgery, the 
incidence of SSI was 17.9%, the majority (71.4%) of the procedures were elective, and the 
operating time was significantly longer than in the other two groups (109.64 – 85.36 min). 
These procedures were performed more often on male patients (64.3 % vs. 35.7%), and 
prophylactic antibiotics were administrated to 53.6% of the patients. Five patients developed 
SSI, and of these, antibiotic prophylaxis had been administrated to only one. Although this is 
a small number of patients, we believe that at each converted laparoscopic cholecystectomy, 
antibiotic prophylaxis should be considered strongly [13]. Superficial incisional SSIs were the 
most often reported infection.We believe this type of SSI is underreported, because post-
discharge surveillance is difficult, and surgeons tend to minimize the importance of this type 
of complication. Biscione et al. reported incomplete post-discharge follow-up in 50.5%of  
about 6,000 cholecystectomy cases,which indicates insufficient surveillance [14]. In our 
study, the post-discharge follow-up rate was 70.3%. Our patents were monitored within 30 
postoperative days, which leaves open the question of unreported cases. In 2010 in Croatia, 
the rate of ESBL Klebsiella pneumoniae isolates resistant to third-generation cephalosporins 
was 34%. During 2010, a somewhat higher number of carbapenemresistant isolates (mostly 
resistant to ertapenem only) were recorded. The first metallo-beta-lactamase (NDM-1)-
producing isolate of K. pneumoniae in Croatia was described in 2009, and during 2010, no 
further NDM-1 isolates were detected among the organisms sent to the Reference Center for 
re-testing for antibiotic resistance surveillance [15]. In the report Surveillance of Healthcare-
Associated Infections in Europe, several countries report their results using the HELICS 
protocol. The overall cumulative incidence of SSIs was 1.43% and in our study 1.44%. The 
number of participating hospitals and data collected differed from one country to another 
(three vs. 296 hospitals; 152 vs. 10,020 operative procedures), which leaves unclear the real 
infection incidence. Hospitals performing at least 20 operative procedures could participate, 
but we believe that more procedures are required for relevant conclusions to be drawn. 
Interventions should be parsed according to the urgency, and when a laparoscopic procedure 
is converted to open surgery, a separate group should be formed [16]. Minimally invasive 
operations carry a lower risk of SSI than do similar procedures done in open fashion. 
Laparoscopic cholecystectomy has become the gold standard because of its safety, 
effectiveness, short hospitalization, and lower cost [7,17,18]. However, open procedures can 
be indicated for patients who have had abdominal surgery and thus have intra-abdominal 
adhesions and those with recent acute cholecystitis or obstructive jaundice [19,20]. By 
conducting this survey, we set a clear basis for SSI monitoring at our hospital. This study 
proved that male gender, open cholecystectomy or laparoscopic cases converted to open 
surgery, and prolonged procedures carry a higher risk. The HELICS protocol is a good 
concept for monitoring SSI, but in case of cholecystectomy, it requires consideration of 
additional elements such as antibiotic appropriateness, gallbladder entry, empyema of the 
gallbladder, obstructive jaundice, previous cholecystitis or pancreatitis, and previous 
abdominal operations. The ASA physical status classification is good to estimate the patients’ 
overall health, but some diseases; for example, diabetes mellitus, or some drugs; for example, 
corticosteroids, have a big impact on the immune system and thus the defense against 
infection. When laparoscopic cholecystectomy has to be converted to open surgery, antibiotic 
prophylaxis should be considered seriously. 
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